A Case of Full Recovery from Prolonged Cardiac Arrest after Infusion with Paclitaxel and Pembrolizumab

Omar Sh Ahmed; Himil Mahadevia; Rami Manochakian; Yujie Zhao; Manisha Salinas; Andras Khoor; Jordan Legout; Yanyan Lou

doi:10.1159/000527205

A Case of Full Recovery from Prolonged Cardiac Arrest after Infusion with Paclitaxel and Pembrolizumab

Omar Sh Ahmed, Himil Mahadevia, Rami Manochakian, Yujie Zhao, Manisha Salinas, Andras Khoor, Jordan Legout, Yanyan Lou

Research output: Contribution to journal › Article › peer-review

Abstract

Lung cancer is one of the most common cancers and has the highest risk of mortality in both genders. This devastating cancer is also a significant financial and emotional burden to patients and the healthcare system. Chemotherapy and immunotherapy have become the cornerstone for the treatment of lung cancer. However, treatment may come with severe and sometimes fatal side effects. In this report, we present the case of a 52-year-old Caucasian male who suffered two episodes of prolonged cardiac arrest after the infusion of paclitaxel and pembrolizumab.

Original language	English (US)
Pages (from-to)	1063-1073
Number of pages	11
Journal	Case Reports in Oncology
Volume	15
Issue number	3
DOIs	https://doi.org/10.1159/000527205
State	Published - Nov 28 2022

Keywords

Cardiotoxicity
Chemotherapy
Immunotherapy
Lung cancer

ASJC Scopus subject areas

Oncology

Access to Document

10.1159/000527205

Cite this

@article{b9f4631f9fbc4e44b3eab525c998307f,

title = "A Case of Full Recovery from Prolonged Cardiac Arrest after Infusion with Paclitaxel and Pembrolizumab",

abstract = "Lung cancer is one of the most common cancers and has the highest risk of mortality in both genders. This devastating cancer is also a significant financial and emotional burden to patients and the healthcare system. Chemotherapy and immunotherapy have become the cornerstone for the treatment of lung cancer. However, treatment may come with severe and sometimes fatal side effects. In this report, we present the case of a 52-year-old Caucasian male who suffered two episodes of prolonged cardiac arrest after the infusion of paclitaxel and pembrolizumab.",

keywords = "Cardiotoxicity, Chemotherapy, Immunotherapy, Lung cancer",

author = "{Sh Ahmed}, Omar and Himil Mahadevia and Rami Manochakian and Yujie Zhao and Manisha Salinas and Andras Khoor and Jordan Legout and Yanyan Lou",

note = "Publisher Copyright: {\textcopyright} 2022 Case Reports in Ophthalmology",

year = "2022",

month = nov,

day = "28",

doi = "10.1159/000527205",

language = "English (US)",

volume = "15",

pages = "1063--1073",

journal = "Case Reports in Oncology",

issn = "1662-6575",

publisher = "S. Karger AG",

number = "3",

}

TY - JOUR

T1 - A Case of Full Recovery from Prolonged Cardiac Arrest after Infusion with Paclitaxel and Pembrolizumab

AU - Sh Ahmed, Omar

AU - Mahadevia, Himil

AU - Manochakian, Rami

AU - Zhao, Yujie

AU - Salinas, Manisha

AU - Khoor, Andras

AU - Legout, Jordan

AU - Lou, Yanyan

PY - 2022/11/28

Y1 - 2022/11/28

N2 - Lung cancer is one of the most common cancers and has the highest risk of mortality in both genders. This devastating cancer is also a significant financial and emotional burden to patients and the healthcare system. Chemotherapy and immunotherapy have become the cornerstone for the treatment of lung cancer. However, treatment may come with severe and sometimes fatal side effects. In this report, we present the case of a 52-year-old Caucasian male who suffered two episodes of prolonged cardiac arrest after the infusion of paclitaxel and pembrolizumab.

AB - Lung cancer is one of the most common cancers and has the highest risk of mortality in both genders. This devastating cancer is also a significant financial and emotional burden to patients and the healthcare system. Chemotherapy and immunotherapy have become the cornerstone for the treatment of lung cancer. However, treatment may come with severe and sometimes fatal side effects. In this report, we present the case of a 52-year-old Caucasian male who suffered two episodes of prolonged cardiac arrest after the infusion of paclitaxel and pembrolizumab.

KW - Cardiotoxicity

KW - Chemotherapy

KW - Immunotherapy

KW - Lung cancer

UR - http://www.scopus.com/inward/record.url?scp=85144105791&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85144105791&partnerID=8YFLogxK

U2 - 10.1159/000527205

DO - 10.1159/000527205

M3 - Article

AN - SCOPUS:85144105791

SN - 1662-6575

VL - 15

SP - 1063

EP - 1073

JO - Case Reports in Oncology

JF - Case Reports in Oncology

IS - 3

ER -

A Case of Full Recovery from Prolonged Cardiac Arrest after Infusion with Paclitaxel and Pembrolizumab

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this